Fenimore Christopher R. bought REGN
August 18, 2026 · Form 4 insider transaction
Fenimore Christopher R. bought 6,283 shares of Regeneron Pharmaceuticals, Inc. at $381.92 per share, a transaction worth $2.40M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,283
Price
$381.92
Total value
$2.40M
InsiderFenimore Christopher R.
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 18, 2026
Filing dateAugust 20, 2026
Shares owned after24,583
OwnershipDirect
10b5-1 planNo
AmendedNo